Year: 2024
Type: article
Study design: Observational Study
Abstract: This cross-sectional study describes national and regional Medicare spending and out-of-pocket costs for tafamidis from its approval in 2019 to 2021.
Source: JAMA Network Open
Authors: Philip J. Blatt, Timothy Simpson, Hongya Chen, Ahmad Masri
Institution: Oregon Health & Science University
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $3,000
OpenAlex ID: W4402514401